PDS Biotechnology Corp expected to post a loss of 44 cents a share - Earnings Preview

PDS Biotechnology

25/03/2024 12:52

* PDS Biotechnology Corp  PDSB.OQ   PDSB.O  is expected
to show no
change in quarterly revenue when it reports  results on March 27
for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for PDS Biotechnology Corp
is for
a loss of 44 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for PDS
Biotechnology
Corp is $17.50​, above​ its last closing price of $4.62. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.44       -0.45      -0.35     Beat    21.5
 Jun. 30 2023  -0.35       -0.35      -0.37     Missed  -6.6
 Mar. 31 2023  -0.31       -0.31      -0.32     Missed  -4.7​
 Dec. 31 2022              -0.29      -0.67     Missed  -133.3
 ​​Sep.        -0.28       -0.28      -0.26     Beat    7.6
 30 2022                                                
 Jun. 30 2022  -0.28       -0.28      -0.20     Beat    29​
 Mar. 31 2022  -0.23       -0.22      -0.32     Missed  -42.9
 Dec. 31 2021  -0.27       -0.24      -0.22     Beat    9
 This summary was machine generated March 25 at 12:52 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)